0001437749-24-003794.txt : 20240212 0001437749-24-003794.hdr.sgml : 20240212 20240212174751 ACCESSION NUMBER: 0001437749-24-003794 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kim Dong CENTRAL INDEX KEY: 0001920163 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 24621647 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA, LTD. STREET 2: 400 ALEXANDER PARK DRIVE, 4TH FLOOR CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4/A 1 rdgdoc.xml FORM 4/A X0508 4/A 2024-01-31 2024-02-02 0001668243 UroGen Pharma Ltd. URGN 0001920163 Kim Dong 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Financial Officer 0 Ordinary Shares 2024-01-31 4 M 0 3333 A 35253 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024. /s/ Jason D. Smith, Attorney-in-Fact 2024-02-12